Covid-19 roundup: As­traZeneca vac­cine halt­ed in Ger­many for be­low-60 pop­u­la­tion; Pfiz­er says Covid-19 vac­cine has 100% ef­fi­ca­cy in chil­dren ages 12-15

Ger­many will stop us­ing As­traZeneca’s Covid-19 vac­cine on res­i­dents be­low the age of 60 due to con­cerns sur­round­ing “rare but fa­tal blood clots,”

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.